华海药业: 浙江华海药业股份有限公司第九届董事会第三次临时会议决议公告

Core Viewpoint - Zhejiang Huahai Pharmaceutical Co., Ltd. held its third temporary meeting of the ninth board of directors on August 15, 2025, where it was decided not to lower the conversion price of the "Huahai Convertible Bonds" [1]. Group 1 - The meeting was attended by all nine directors, meeting the legal quorum requirements [1]. - The resolution regarding the non-adjustment of the conversion price for the "Huahai Convertible Bonds" was passed unanimously with 9 votes in favor and no votes against or abstentions [1]. - The details of the resolution will be published in various financial newspapers and on the Shanghai Stock Exchange website [1].